Research Article
[Retracted] Antileukemic Effects of Anti-miR-146a, Anti-miR-155, Anti-miR-181a, and Prednisolone on Childhood Acute Lymphoblastic Leukemia
Table 6
JC-1 results of SUP-B15 and NCI-BL 2171 cells.
| Treatment group | Live cell (%) | Apoptotic cell (%) | Apoptotic fold change (to control) | SUP-B15 | NCI-BL 2171 | SUP-B15 | NCI-BL 2171 | SUP-B15 | NCI-BL 2171 |
| Control | 92.30 | 74.10 | 7.60 | 20.90 | 1.00 | 1.00 | IC50 dose of prednisolone | 0.30 | 76.30 | 99.70 | 17.60 | 13.10 | 0.80 | Anti-miR-146a | 79.20 | 68.70 | 20.60 | 24.80 | 2.70 | 1.20 | Anti-miR-146a & IC50 dose of prednisolone | 5.40 | 47.10 | 94.50 | 43.40 | 12.40 | 2.10 | Anti-miR-155 | 75.40 | 64.20 | 24.30 | 29.40 | 3.20 | 1.40 | Anti-miR-155 & IC50 dose of prednisolone | 16.20 | 49.80 | 83.80 | 40.10 | 11.00 | 1.90 | Anti-miR-181a | 86.20 | 73.10 | 13.70 | 21.30 | 1.80 | 1.00 | Anti-miR-181a & IC50 dose of prednisolone | 15.00 | 58.20 | 83.30 | 33.20 | 11.00 | 1.60 | Anti-let-7e | 80.00 | 69.50 | 19.20 | 23.10 | 2.50 | 1.10 | Anti-let-7e & IC50 dose of prednisolone | 16.00 | 59.70 | 84.00 | 31.70 | 11.10 | 1.50 | Anti-miR-146a + anti-miR-155 + anti-miR-181a + anti-let-7e combination | 79.90 | 72.50 | 19.80 | 20.90 | 2.60 | 1.00 | Anti-miR-146a + anti-miR-155 + anti-miR-181a + anti-let-7e combination & IC50 dose of prednisolone | 3.90 | 59.60 | 96.10 | 30.80 | 12.60 | 1.50 |
|
|
Fisher’s exact test, <0.01 and <0.001. |